Younger adults · Pennsylvania
Studies for younger adults in Pennsylvania
These studies accept adults from 21 or younger and set an upper age limit of 45 or below, so they are aimed at younger adults. Being in the age range does not mean you qualify; screening decides.
59 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18–45
- RecruitingHealthy volunteersEarly Phase 1
Imaging Mitochondrial Complex-I in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study
Rajesh Narendran
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18–45
- RecruitingHealthy volunteersEarly Phase 1
Endometriosis and Microvascular Dysfunction: Role of Inflammation
Penn State University
- Location
- University Park, PA
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Autonomic Control of the Circulation and VDR
Milton S. Hershey Medical Center
- Location
- Hershey, PA
- Eligibility basics
- Ages 21–35
- RecruitingPhase 3
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
UCB BIOSCIENCES, Inc.
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 5–35
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Philadelphia, PA + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Philadelphia, PA + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Regeneron Pharmaceuticals
- Location
- Erie, PA + 9 other US sites
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingPhase 1
A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
Solid Biosciences Inc.
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 18–40
- RecruitingPhase 2
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Mirum Pharmaceuticals, Inc.
- Location
- Media, PA + 13 other US sites
- Eligibility basics
- Ages 13–45 · Men only
- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Allentown, PA + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Philadelphia, PA + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Bryn Mawr, PA + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- RecruitingPhase 3
Study of ALK-001 on the Progression of Stargardt Disease
Alkeus Pharmaceuticals, Inc.
- Location
- Erie, PA + 11 other US sites
- Eligibility basics
- Ages 8–45
- RecruitingPhase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
Alnylam Pharmaceuticals
- Location
- Pittsburgh, PA + 5 other US sites
- Eligibility basics
- Ages 16–45 · Women only
- RecruitingPhase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 4 other US sites
- Eligibility basics
- Ages 2–18
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Camp Hill, PA + 78 other US sites
- Eligibility basics
- Ages 18–45
- Recruiting
A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
Ksana Health
- Location
- Pittsburgh, PA + 1 other US site
- Eligibility basics
- Ages 13–24
- RecruitingPhase 3
Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 3 other US sites
- Eligibility basics
- Ages 2–18
- RecruitingPhase 3
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Praxis Precision Medicines
- Location
- Philadelphia, PA + 5 other US sites
- Eligibility basics
- Ages 0 mo–18
- Recruiting
Pediatric Percutaneous Ultrasound Gastrostomy Technique
CoapTech
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 0 mo–21
- Recruiting
Mindfulness Training and Respiration Biosignal Feedback - Study 2
Equa Health
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18–30
- Recruiting
STEPS - Stress Training and Engagement Via Phone-Based Systems
Equa Health
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18–30
- RecruitingPhase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN Therapeutics, Inc.
- Location
- Philadelphia, PA + 15 other US sites
- Eligibility basics
- Ages 1 mo–18